1. Home
  2. NRSN vs ARBB Comparison

NRSN vs ARBB Comparison

Compare NRSN & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • ARBB
  • Stock Information
  • Founded
  • NRSN 2017
  • ARBB 1997
  • Country
  • NRSN Israel
  • ARBB Singapore
  • Employees
  • NRSN N/A
  • ARBB N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • ARBB EDP Services
  • Sector
  • NRSN Health Care
  • ARBB Technology
  • Exchange
  • NRSN Nasdaq
  • ARBB Nasdaq
  • Market Cap
  • NRSN 17.8M
  • ARBB 14.9M
  • IPO Year
  • NRSN 2021
  • ARBB 2023
  • Fundamental
  • Price
  • NRSN $1.09
  • ARBB $0.52
  • Analyst Decision
  • NRSN Hold
  • ARBB
  • Analyst Count
  • NRSN 1
  • ARBB 0
  • Target Price
  • NRSN N/A
  • ARBB N/A
  • AVG Volume (30 Days)
  • NRSN 374.5K
  • ARBB 158.4K
  • Earning Date
  • NRSN 12-18-2024
  • ARBB 11-22-2024
  • Dividend Yield
  • NRSN N/A
  • ARBB N/A
  • EPS Growth
  • NRSN N/A
  • ARBB N/A
  • EPS
  • NRSN N/A
  • ARBB N/A
  • Revenue
  • NRSN N/A
  • ARBB $12,334,474.00
  • Revenue This Year
  • NRSN N/A
  • ARBB N/A
  • Revenue Next Year
  • NRSN N/A
  • ARBB N/A
  • P/E Ratio
  • NRSN N/A
  • ARBB N/A
  • Revenue Growth
  • NRSN N/A
  • ARBB N/A
  • 52 Week Low
  • NRSN $0.51
  • ARBB $0.22
  • 52 Week High
  • NRSN $2.33
  • ARBB $4.55
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 47.35
  • ARBB 49.89
  • Support Level
  • NRSN $1.01
  • ARBB $0.52
  • Resistance Level
  • NRSN $1.13
  • ARBB $0.75
  • Average True Range (ATR)
  • NRSN 0.09
  • ARBB 0.08
  • MACD
  • NRSN -0.01
  • ARBB 0.00
  • Stochastic Oscillator
  • NRSN 27.27
  • ARBB 34.15

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.

Share on Social Networks: